Latin American Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin American Newswire.

Press releases published on July 9, 2026

Nimble.LA duplica nuevos negocios y crea Directorio y Consejo Asesor ante el auge de la IA
Smart City Solar Platform Solutions
Institute of the Americas Releases Sustainability Tech Assessment for LAC Municipalities
DOXA® Talent Earns Great Place To Work® Certification in the Philippines and Colombia
The Advocacy Circle Urges Parents to Review 504 Plan Implementation Before the New School Year
Accelevate Solutions Unveils EBAI™ 3.0, Transforming Fleet Operations Through Autonomous AI & Financial Intelligence
XS.com fortalece sua expansão global com a nomeação de Emily A. Aghajanyan como Diretora para Mercados Emergentes
 XS.com fortalece su expansión global con el nombramiento de Emily A. Aghajanyan como Directora para Mercados Emergentes
BingX Expands Tradfi Offerings with 1,000,000 USDT Earnings Season Campaign
China and Mexico Hold Dialogue in Mexico City on a “Green Future” and Mutual Learning Among Civilizations
China y México celebran en Ciudad de México diálogo por “futuro verde” y aprendizaje mutuo entre civilizaciones
Future Caribbean's Global AI Movement Accelerates with Inaugural Agentic AI Assembly, Recruitment Continues Worldwide
Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of  QRX003 in Peeling Skin Syndrome
Alkeus Pharmaceuticals Announces Gildeuretinol Data Presentations During the American Society of Retina Specialists (ASRS) 44th Annual Meeting July 15 - 18
Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate
Blue Gold Ltd Announces Initiatives to Regain Nasdaq Compliance and Strengthen its Financial Position
Streaming triples in Brazil, lifting total World Cup audience by 22%, LiveMode analysis finds
Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026
Atsena Therapeutics Selects ATSN-401 Clinical Candidate, a Potential Best-in-Class Gene Therapy for Stargardt Disease
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Latin American Newswire

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.